PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) announced its participation in three upcoming investor conferences. The events include the Raymond James 44th Annual Institutional Investor Conference on March 6 at 8:05 a.m. EST, the Cowen 43rd Annual Health Care Conference on March 7 at 12:50 p.m. EST, and the Barclays Global Healthcare Conference on March 14 at 8:00 a.m. EST. Each presentation will be webcast live and archived on the company's Events and Presentations page for 30 days. PTC specializes in developing innovative medicines for rare disorders.

SOUTH PLAINFIELD, N.J., Feb. 21, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:

Raymond James 44^th Annual Institutional Investor Conference
Monday, March 6, at 8:05 a.m. EST

Cowen 43^rd Annual Health Care Conference
Tuesday, March 7, at 12:50 p.m. EST

Barclays Global Healthcare Conference
Tuesday, March 14, at 8:00 a.m. EST

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection. 

About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The Company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and LinkedIn.

For More Information:

Investors:
Kylie O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-301750360.html

SOURCE PTC Therapeutics, Inc.

FAQ

What conferences is PTC Therapeutics participating in March 2023?

PTC Therapeutics will participate in the Raymond James 44th Annual Institutional Investor Conference on March 6, Cowen 43rd Annual Health Care Conference on March 7, and Barclays Global Healthcare Conference on March 14, 2023.

What time will PTC Therapeutics present at the Raymond James conference?

PTC Therapeutics will present at the Raymond James 44th Annual Institutional Investor Conference on March 6, 2023, at 8:05 a.m. EST.

Where can I watch the PTC Therapeutics presentations?

The presentations will be webcast live and can be accessed on the Events and Presentations page of PTC Therapeutics' website.

How long will the PTC Therapeutics conference webcasts be available?

The webcasts of the PTC Therapeutics presentations will be available for 30 days following each event.

What is the focus of PTC Therapeutics as a biopharmaceutical company?

PTC Therapeutics focuses on the discovery, development, and commercialization of clinically differentiated medicines for patients with rare disorders.